WTB
EPZM

Washington Trust Bank’s Epizyme, Inc EPZM Stock Holding History

Washington Trust Bank’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-200
Closed -$3K – 830
2015
Q4 		$3K Hold
200
– – ﹤0.01% 688
2015
Q3 		$3K Buy
+200
New +$4.04K ﹤0.01% 725

Other funds holding EPZM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Washington Trust Bank's EPZM Position: Q1 2016 in Review

Washington Trust Bank sold out of Epizyme, Inc (EPZM) in Q1 2016, closing a stake of 200 shares — an estimated $3K sold.

Washington Trust Bank first reported a position in EPZM in Q3 2015 and held it in 2 quarters. The position peaked at $3K in Q4 2015. 91 funds tracked by Wall St. Rank hold EPZM as of Q1 2016.

  • Washington Trust Bank reported no remaining Epizyme, Inc position as of Q1 2016 after selling out during the quarter.
  • Washington Trust Bank sold 200 Epizyme, Inc shares in Q1 2016, an estimated $3K.
  • Washington Trust Bank first reported a position in Epizyme, Inc in Q3 2015 and held it in 2 quarters.
  • Washington Trust Bank's Epizyme, Inc position peaked at $3K in Q4 2015.
  • 91 funds tracked by Wall St. Rank held Epizyme, Inc as of Q1 2016.

Based on Washington Trust Bank's 13F filing for Q1 2016, filed 25 Apr 2016.